COLLAGENASE LIPOSOME INHALANT AND USE THEREOF IN TREATMENT OF PULMONARY FIBROSIS
A collagenase liposome inhalant, used for treating pulmonary fibrosis after pulmonary inhalation. Use of a collagenase liposome in the preparation of an inhalant for treating pulmonary fibrosis, and a preparation method for the collagenase liposome inhalant. The collagenase liposome inhalant is selected from a nebulized inhalant and a powder inhalation. The collagenase liposome nebulized inhalant is nebulized into fine liquid droplets by means of a nebulizer and then orally inhaled into the lung for administration, and the collagenase liposome is concentrated on the lung to play a role. The collagenase liposome powder inhalation is actively inhaled into the lung by means of a dry powder inhaler..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 29. Feb. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
JIN YIGUANG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-29, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
WO2024041415 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA001196278 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA001196278 | ||
| 003 | DE-627 | ||
| 005 | 20240329161002.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA001196278 | ||
| 035 | |a (EPA)WO2024041415 | ||
| 035 | |a (EPA)84198103 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a JIN YIGUANG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COLLAGENASE LIPOSOME INHALANT AND USE THEREOF IN TREATMENT OF PULMONARY FIBROSIS |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-29, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 | ||
| 520 | |a A collagenase liposome inhalant, used for treating pulmonary fibrosis after pulmonary inhalation. Use of a collagenase liposome in the preparation of an inhalant for treating pulmonary fibrosis, and a preparation method for the collagenase liposome inhalant. The collagenase liposome inhalant is selected from a nebulized inhalant and a powder inhalation. The collagenase liposome nebulized inhalant is nebulized into fine liquid droplets by means of a nebulizer and then orally inhaled into the lung for administration, and the collagenase liposome is concentrated on the lung to play a role. The collagenase liposome powder inhalation is actively inhaled into the lung by means of a dry powder inhaler. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHANG TONGTONG |4 aut | |
| 700 | 0 | |a ZHANG HUI |4 aut | |
| 700 | 0 | |a LIU YAN |4 aut | |
| 700 | 0 | |a YUAN BOCHUAN |4 aut | |
| 700 | 0 | |a DU LINA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 29. Feb. |
| 773 | 1 | 8 | |g year:2024 |g day:29 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/84198103/publication/WO2024041415A1?q=WO2024041415 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 29 |c 02 | ||